Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: Revised recommendations for the use of contraceptive methods during the postpartum period

Morbidity and Mortality Weekly Report

Volumn 60, Issue 26, 2011, Pages 878-883

  Tepper, Naomi K ^a   Curtis, Kathryn M ^a   Jamieson, Denise J ^a   Marchbanks, Polly A ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CONTRACEPTION; DRUG CONTRAINDICATION; FEMALE; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; RISK FACTOR; UNPLANNED PREGNANCY; VENOUS THROMBOEMBOLISM;

CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY, UNPLANNED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79960240037     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Contraceptive use among postpartum women---12 states and New York City, 2004--2006. MMWR 2009;58:821--6.
2. CDC. U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th edition. MMWR 2010;59(No. RR-4).
3. Gipson JD, Koenig MA, Hindin MJ. The effects of unintended pregnancy on infant, child, and parental health: a review of the literature. Stud Family Plann 2008;39:18--38.
4. Zhu BP. Effect of interpregnancy interval on birth outcomes: findings from three recent US studies. Int J Gynecol Obstet 2005;89(Suppl 1):S25--33.
5. Jackson E, Glasier A. Return of ovulation and menses in postpartum, non-lactating women: a systematic review. Obstet Gynecol 2011;117:657--62.
6. World Health Organization. Combined hormonal contraceptive use during the postpartum period. Geneva, Switzerland: World Health Organization; 2010. Available at http://www.who.int/reproductivehealth/publications/family_planning/rhr_10_15/en/index.html. Accessed June 30, 2011.
7. Jackson E, Curtis K, Gaffield M. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 2011;117:691--703.
8. Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception 2010;82:10--6.
9. Kapp N, Curtis KM. Intrauterine device insertion during the postpartum period: a systematic review. Contraception 2009;80:327--36.
10. Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2010;116:1079--87.